Immunohistochemical pattern of c-MYC protein judged as “+/(weak)+/−” by a new notation correlates with MYC gene nontranslocation in large B-cell lymphoma-Reference-Cited by-同舟云学术

Immunohistochemical pattern of c-MYC protein judged as “+/(weak)+/−” by a new notation correlates with MYC gene nontranslocation in large B-cell lymphoma

Published:2019-03 Issue: Volume:85 Page:112-118
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Fujishima Fumiyoshi,Katsushima Hiroki,Fukuhara Noriko,Konosu-Fukaya Sachiko,Nakamura Yasuhiro,Usubuchi Hajime,Sato Satoko,Ota Yasunori,Yashima-Abo Akiko,Nakamura Tomohiro,Nakaya Naoki,Harigae Hideo,Sasano Hironobu,Ichinohasama Ryo

Funder

Japan Society for the Promotion of Science

Public Interest Incorporated Foundation of Ichinohasama Memorial READ Blood Academy

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference14 articles.

1. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009;Goldhirsch;Ann Oncol,2009

2. KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer;Takeuchi;Clin Cancer Res,2009

3. CH5424802 (RO5424802) for patients with ALK-rearranged advanced non–small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study;Seto;Lancet Oncol,2013

4. Pembrolizumab versus docetaxel for previously treated, PD-L1–positive, advanced non–small-cell lung cancer (KEYNOTE-010): a randomised controlled trial;Herbst;Lancet,2016

5. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer;Harvey;J Clin Oncol,1999

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MMR markers correlate with clinical outcome in patients with esophageal squamous cell carcinoma;The International Journal of Biological Markers;2023-04-03

2. 本邦初・悪性リンパ腫疑い症例のための統合診断システム/READsystem―誕生～現在～近未来構想―;Skin Cancer;2022

3. Utility of a new notation to visualize flow cytometry analysis results: first preliminary comparison with immunohistochemistry to detect CD30 expression on T-cell lymphoma cells;BMC Cancer;2021-12